Which medications are contraindicated in patients with paramyotonia congenita?

Medication Contraindications in Paramyotonia Congenita

Succinylcholine is absolutely contraindicated in patients with paramyotonia congenita due to the risk of life-threatening hyperkalemia and cardiac arrest, and acetazolamide should be avoided as it can precipitate severe quadriparesis despite improving myotonia.

Absolute Contraindications

Depolarizing Muscle Relaxants

• Succinylcholine must never be used in paramyotonia congenita patients 1, 2
• This agent causes severe hyperkalemia through disruption of unstable muscle cell membranes, leading to rhabdomyolysis and potential cardiac arrest
• The risk applies to all neuromuscular diseases with primary muscle damage or up-regulation of nicotinic acetylcholine receptors 2
• This contraindication extends to any patient with neuromuscular disease undergoing anesthesia 3

Carbonic Anhydrase Inhibitors

• Acetazolamide is contraindicated despite being effective for other forms of periodic paralysis 4
• Clinical evidence demonstrates acetazolamide produces severe quadriparesis in paramyotonia congenita patients, even while abolishing myotonia 4
• This distinguishes paramyotonia congenita from hypokalemic and hyperkalemic periodic paralysis, where acetazolamide is beneficial 4

Medications Requiring Extreme Caution

Volatile Anesthetic Agents

• Inhaled anesthetics (halothane, isoflurane, sevoflurane) should be avoided 1
• These agents increase risk of extreme hyperthermic events and rhabdomyolysis in patients with muscular dystrophies and related disorders
• While the evidence specifically addresses Duchenne muscular dystrophy, the mechanism of muscle membrane instability applies to paramyotonia congenita
• Use total intravenous anesthesia (TIVA) with propofol and short-acting opioids instead 1

Potassium-Altering Medications

• Avoid potassium-sparing diuretics (spironolactone, triamterene, amiloride) which may cause severe hyperkalemia 5
• Exercise caution with any medication that significantly affects serum potassium levels given the underlying channelopathy

Safe Anesthetic Alternatives

When anesthesia is required:

• Propofol for induction and maintenance 1
• Non-depolarizing muscle relaxants (rocuronium, vecuronium) if paralysis is necessary 1, 2
  • Note: Dose adjustments may be required as sensitivity can be altered in neuromuscular diseases
  • Neuromuscular monitoring is essential 2
• Fentanyl or remifentanil for analgesia 6
• Local anesthetics (lidocaine, bupivacaine) are safe 6

Treatment Options (Not Contraindicated)

For context, these medications are considered safe and potentially beneficial:

• Mexiletine (sodium channel blocker) - first-line symptomatic treatment 7
• Ranolazine - shown to improve stiffness, weakness, and myotonia 8
• Buprenorphine - emerging evidence shows improvement in pain, stiffness, and exercise-induced paralysis 9
• Lacosamide - non-antiarrhythmic sodium channel blocker option 9

Critical Perioperative Considerations

• Multidisciplinary team including anesthesiology with neuromuscular disease expertise is mandatory 1, 6
• Avoid temperature extremes (hypothermia or hyperthermia) which can trigger mast cell activation or worsen myotonia 6
• Have emergency medications immediately available, including epinephrine for severe reactions 6
• Monitor continuously with pulse oximetry and capnography 1
• ICU availability for postprocedure care is essential 1

Common Pitfall to Avoid

The most dangerous error is assuming acetazolamide is safe because it works for other periodic paralyses. Acetazolamide specifically worsens weakness in paramyotonia congenita despite improving myotonia, making it uniquely contraindicated in this condition 4, 10.